Oxomics
Oxomics is an innovative company developing a novel and revolutionary cancer diagnostics technology that fits into clinical workflows. Their technology uses NMR metabolomics, profiling natural chemicals (metabolites) in the blood, to detect cancer and its metastatic status with high accuracy. The company aims to provide a fast, inexpensive, and easy-to-use blood test for early cancer detection, potentially usable by GPs. Oxomics has received significant funding, including £1.25m from Innovate UK Biomedical Catalyst, and has published research in Clinical Cancer Research demonstrating high accuracy in detecting cancer and its spread.
Oxomics
Oxomics is an innovative company developing a novel and revolutionary cancer diagnostics technology that fits into clinical workflows. Their technology uses NMR metabolomics, profiling natural chemicals (metabolites) in the blood, to detect cancer and its metastatic status with high accuracy. The company aims to provide a fast, inexpensive, and easy-to-use blood test for early cancer detection, potentially usable by GPs. Oxomics has received significant funding, including £1.25m from Innovate UK Biomedical Catalyst, and has published research in Clinical Cancer Research demonstrating high accuracy in detecting cancer and its spread.